{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:30:56Z","timestamp":1761964256312,"version":"build-2065373602"},"reference-count":67,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.revmed.2009.04.010","type":"journal-article","created":{"date-parts":[[2010,4,12]],"date-time":"2010-04-12T03:28:23Z","timestamp":1271042903000},"page":"353-360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Infections opportunistes non tuberculeuses au cours des traitements par les anti-TNF\u03b1"],"prefix":"10.1016","volume":"31","author":[{"given":"I.","family":"Marie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Guglielmino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2009.04.010_bib1","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jbspin.2005.10.004","article-title":"The RATIO observatory: French registry of opportunistic infections, severe bacterial infections, and lymphomas complicating anti-TNF-alpha therapy","volume":"72","author":"Tubach","year":"2005","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.revmed.2009.04.010_bib2","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/art.22504","article-title":"Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor-\u03b1 antagonists","volume":"56","author":"Curtis","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2009.04.010_bib3","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/383317","article-title":"Granulomatous infectious diseases associated with tumour necrosis factor antagonists","volume":"38","author":"Wallis","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2009.04.010_bib4","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1086\/424455","article-title":"Granulomatous infectious diseases associated with tumour necrosis factor antagonists: correction","volume":"39","author":"Wallis","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2009.04.010_bib5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1183\/09031936.00125607","article-title":"Re-activation of bovine tuberculosis in a patient, treated with infliximab","volume":"32","author":"Larsen","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2009.04.010_bib6","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/thx.2005.056952","article-title":"Fatal pulmonary Mycobacterium xenopi in a patient with rheumatoid arthritis receiving etanercept","volume":"62","author":"Maimon","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.revmed.2009.04.010_bib7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2133.2005.06431.x","article-title":"Fatal fulminant legionnaire's disease in a patient with severe erythrodermic psoriasis treated with infliximab after long-term steroid","volume":"152","author":"Eisendle","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.revmed.2009.04.010_bib8","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1086\/508538","article-title":"Emergence of Legionella pneumophila pneumonia in patients receiving tumor necrosis factor-alpha antagonists","volume":"43","author":"Tubach","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2009.04.010_bib9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ibd.20286","article-title":"Severe Listeria meningoencephalitis in an infliximab-tretaed patient with Crohn's disease","volume":"14","author":"Izbeki","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.revmed.2009.04.010_bib10","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/art.20876","article-title":"Septic arthritis due to Listeria monocytogenes in a patient receiving etanercept","volume":"52","author":"Rachapalli","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2009.04.010_bib11","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1128\/JCM.43.5.2537-2541.2005","article-title":"Listeria-associated arthritis in a patient undergoing etanercept therapy: case report and review of the literature","volume":"43","author":"Schett","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.revmed.2009.04.010_bib12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/art.10758","article-title":"Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor-\u03b1 neutralizing agents","volume":"48","author":"Slifman","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2009.04.010_bib13","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/rheumatology\/keh700","article-title":"Fatal Mycobacterium peregrinum pneumonia in refractory polymyositis treated with infliximab","volume":"44","author":"Marie","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2009.04.010_bib14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jinf.2008.04.010","article-title":"Bilateral pneumonia by Mycobacterium aurum in a patient receiving infliximab therapy","volume":"57","author":"Mart\u00edn-Aspas","year":"2008","journal-title":"J Infect"},{"key":"10.1016\/j.revmed.2009.04.010_bib15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jinf.2007.08.007","article-title":"Mycobacterium other than tuberculosis (MOTT) infection: an emerging disease in infliximab-treated patients","volume":"55","author":"Salvana","year":"2007","journal-title":"J Infect"},{"key":"10.1016\/j.revmed.2009.04.010_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/09273940600678062","article-title":"Visual recovery following Mycobacterium chelonae endophtalmitis","volume":"14","author":"Stewart","year":"2006","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2009.04.010_bib17","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/ncprheum0538","article-title":"Pulmonary Mycobacterium szulgai infection and treatment in a patient receiving antitumor necrosis factor therapy","volume":"3","author":"van Ingen","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.revmed.2009.04.010_bib18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/qjmed\/hcn028","article-title":"Pulmonary actinomycosis in a patient with diffuse systemic sclerosis treated with infliximab","volume":"101","author":"Marie","year":"2008","journal-title":"QJM"},{"key":"10.1016\/j.revmed.2009.04.010_bib19","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1503\/cmaj.1040563","article-title":"Cutaneous nocardiosis complicating management of Crohn's disease with infliximab and prednisone","volume":"171","author":"Singh","year":"2004","journal-title":"CMAJ"},{"key":"10.1016\/j.revmed.2009.04.010_bib20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0025-6196(11)60839-2","article-title":"Fungal infections complicating tumor necrosis factor alpha blockade therapy","volume":"83","author":"Tsiodras","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.revmed.2009.04.010_bib21","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1007\/s10620-006-9575-5","article-title":"Pneumocystis pneumonia during combing therapy of infliximab, corticosteroid, and azathioprine in a patient with Crohn's disease","volume":"52","author":"Itaba","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.revmed.2009.04.010_bib22","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1183\/09031936.05.00005205","article-title":"Cough and fever in a female with Crohn's disease receiving infliximab","volume":"26","author":"Statakos","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2009.04.010_bib23","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s10620-006-9250-x","article-title":"Pneumocystis jiroveci (carinii) pneumonia after infliximab therapy: a review of 84\u00a0cases","volume":"52","author":"Kaur","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.revmed.2009.04.010_bib24","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1056\/NEJMc070728","article-title":"Pneumocystis pneumonia associated with infliximab in Japan","volume":"357","author":"Harigai","year":"2007","journal-title":"N Engl Med J"},{"key":"10.1016\/j.revmed.2009.04.010_bib25","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1365-2559.2006.02488.x","article-title":"Angio-invasive aspergillosis presenting as neutropenic colitis","volume":"49","author":"Finn","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/j.revmed.2009.04.010_bib26","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/rheumatology\/ken088","article-title":"Central nervous system Aspergillus fumigatus presenting as cranial nerve palsy in a patient with ankylosing spondylitis on anti-TNF therapy","volume":"47","author":"Slusher","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2009.04.010_bib27","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJM200104053441415","article-title":"Invasive pulmonary aspergillosis associated with infliximab therapy","volume":"344","author":"Warris","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2009.04.010_bib28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0210-5705(03)70477-4","article-title":"Candidiasis sist\u00e9mica y tratamiento con infliximab","volume":"27","author":"Belda","year":"2004","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.revmed.2009.04.010_bib29","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/ard.2006.066761","article-title":"Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: The research in active rheumatoid arthritis (ReAct) trial","volume":"66","author":"Burmester","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2009.04.010_bib30","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s10096-004-1185-6","article-title":"Cavitating pneumonia after infliximab and prednisone","volume":"23","author":"Arend","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.revmed.2009.04.010_bib31","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/j.jaad.2006.12.015","article-title":"Disseminated Cryptococcus neoformans after treatment with infliximab for rheumatoid arthritis","volume":"58","author":"Kozic","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.revmed.2009.04.010_bib32","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.diagmicrobio.2006.10.014","article-title":"Cryptococcal meningitis in a patient treated with infliximab","volume":"57","author":"Munoz","year":"2007","journal-title":"Diag Microbiol Infect Dis"},{"key":"10.1016\/j.revmed.2009.04.010_bib33","first-page":"606","article-title":"Pneumonia due Cryptococcus neoformans in a patient receiving infliximab: possible zoonotic transmission from a pet cockatiel","volume":"49","author":"Shrestha","year":"2004","journal-title":"Respir Care"},{"key":"10.1016\/j.revmed.2009.04.010_bib34","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/ncpgasthep1119","article-title":"Infliximab-induced disseminated histoplasmosis in a patient with Crohn's disease","volume":"5","author":"Galandiuk","year":"2008","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.revmed.2009.04.010_bib35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0002-9343(01)00945-7","article-title":"Reactivation of histoplasmosis after treatment with infliximab","volume":"112","author":"Nakelchik","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2009.04.010_bib36","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1002\/art.10583","article-title":"Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor-\u03b1 antagonists: infliximab and etanercept","volume":"46","author":"Lee","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2009.04.010_bib37","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1136\/ard.2005.043166","article-title":"Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis","volume":"65","author":"Schiff","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2009.04.010_bib38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1089\/sur.2006.039","article-title":"Invasive mucormycosis of the maxillary sinus: extensive destruction with an indolent presentation","volume":"9","author":"Odessey","year":"2008","journal-title":"Surg Infect"},{"key":"10.1016\/j.revmed.2009.04.010_bib39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1442-9071.2007.01458.x","article-title":"Disseminated mucormycosis and orbital ischaemia in combination immunosuppression with a tumor necrosis factor-\u03b1 inhibitor","volume":"35","author":"Singh","year":"2007","journal-title":"Clin Exp Ophtalmol"},{"key":"10.1016\/j.revmed.2009.04.010_bib40","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2310\/7750.2007.00009","article-title":"Invasive Tripchophyton rubrum infection and long-term prednisone treatment","volume":"11","author":"Lowther","year":"2007","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.revmed.2009.04.010_bib41","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1086\/377235","article-title":"Disseminated Sporotrichosis associated with treatment with immunosuppressants and tumor necrosis factor-\u03b1 antagonists","volume":"37","author":"Gottlieb","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2009.04.010_bib42","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10096-008-0628-x","article-title":"Risk factors for opportunistic infections in infliximab-treated patients: the importance of screening in prevention","volume":"28","author":"Garcia-Vidal","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.revmed.2009.04.010_bib43","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1111\/j.1572-0241.2004.41389_7.x","article-title":"Disseminated primary varicella after initiation of infliximab for Crohn's disease","volume":"99","author":"Leung","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.revmed.2009.04.010_bib44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.gastro.2003.10.047","article-title":"The safety profile of infliximab in patients with Crohn's disease: the Mayo Clinic experience in 500\u00a0patients","volume":"126","author":"Colombel","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.revmed.2009.04.010_bib45","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1440-0960.2005.00170.x","article-title":"Pyoderma gangrenosum complicated by herpes simplex infection","volume":"46","author":"Tai","year":"2005","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.revmed.2009.04.010_bib46","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.3748\/wjg.14.2912","article-title":"Cytomegalovirus colitis in a patient with Behcet's disease receiving tumor necrosis factor alpha inhibitory treatment","volume":"14","author":"Sari","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.revmed.2009.04.010_bib47","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ibd.20131","article-title":"Infliximab and the risk of latent viruses reactivation in active Crohn's disease","volume":"13","author":"Lavagna","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.revmed.2009.04.010_bib48","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jcv.2008.06.002","article-title":"Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNF-\u03b1 therapy","volume":"43","author":"D\u2019Ovidio","year":"2008","journal-title":"J Clin Virol"},{"key":"10.1016\/j.revmed.2009.04.010_bib49","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1086\/425123","article-title":"Cytomegalovirus retinitis in a patient treated with antitumor necrosis factor alpha antibody therapy for rheumatoid arthritis","volume":"39","author":"Haerter","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2009.04.010_bib50","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.22783","article-title":"Long-term treatment with methotrexate or tumor necrosis factor-\u03b1 inhibitors does not increase Epstein-Barr virus load in patients with rheumatoid arthritis","volume":"57","author":"Balandraud","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2009.04.010_bib51","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/ibd.20035","article-title":"Occult hepatitis\u00a0B and infliximab-induced HBV reactivation","volume":"13","author":"Madonia","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.revmed.2009.04.010_bib52","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3748\/wjg.v12.i6.974","article-title":"Subfulminant hepatitis\u00a0B after infliximab in Crohn's disease: need for HBV-screening?","volume":"12","author":"Millionig","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.revmed.2009.04.010_bib53","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1478-3231.2007.01665.x","article-title":"Hepatitis\u00a0B reactivation during therapy with etanercept in an HBs-Ag-negative and anti-HBs-positive patient","volume":"28","author":"Montiel","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.revmed.2009.04.010_bib54","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/rheumatology\/kem082","article-title":"Chronic viral hepatitis and TNF-\u03b1 blockade","volume":"46","author":"Raftery","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2009.04.010_bib55","first-page":"421","article-title":"Short-term course of chronic hepatitis\u00a0B and C under treatment with etanercept associated with different disease modifying drugs without antiviral prophylaxis","volume":"35","author":"Cansu","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2009.04.010_bib56","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/art.21949","article-title":"Concomitant interferon-\u03b1 therapy and tumor necrosis factor-\u03b1 inhibition for rheumatoid arthritis and hepatitis\u00a0C","volume":"54","author":"Niewold","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2009.04.010_bib57","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/ard.62.11.1078","article-title":"Effect of tumor necrosis factor-\u03b1 antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis\u00a0C infection","volume":"62","author":"Peterson","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2009.04.010_bib58","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/rheumatology\/kel191","article-title":"Etanercept treatment for 3\u00a0months is safe in patients with rheumatological manifestations associated with hepatitis\u00a0C virus","volume":"46","author":"Marotte","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2009.04.010_bib59","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/ard.2007.081513","article-title":"The use of antitumour necrosis factor therapy in HIV-positive individuals with rheumatic disease","volume":"67","author":"Cepeda","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2009.04.010_bib60","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1001\/archinte.166.16.1783","article-title":"Infliximab and human immunodeficiency virus infection: viral load reduction and CD4+ T cell loss related to apoptosis","volume":"166","author":"Filippi","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.revmed.2009.04.010_bib61","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1136\/ard.62.7.684","article-title":"Kaposi's sarcoma associated with tumour necrosis factor-\u03b1 neutralizing therapy","volume":"62","author":"Cohen","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2009.04.010_bib62","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1056\/NEJMc051556","article-title":"Infliximab and reactivation of cerebral toxoplasmosis","volume":"353","author":"Young","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2009.04.010_bib63","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/rheumatology\/kel235","article-title":"Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab","volume":"45","author":"Bassetti","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2009.04.010_bib64","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10067-007-0775-y","article-title":"Visceral leishmaniasis in a patient with psoriatic arthritis treated with infliximab: reactivation of a latent infection?","volume":"27","author":"Tektonidou","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.revmed.2009.04.010_bib65","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/art.20882","article-title":"Clinical infection with Strongyloides stercoralis following etanercept use for rheumatoid arthritis","volume":"52","author":"Boatright","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2009.04.010_bib66","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.lpm.2008.09.021","article-title":"Infections au cours des polymyosites et des dermatomyosites","volume":"38","author":"Marie","year":"2009","journal-title":"Presse Med"},{"key":"10.1016\/j.revmed.2009.04.010_bib67","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1056\/NEJMoa032655","article-title":"Fatal myositis due to the microsporidian Brachiola algerae, a mosquito pathogen","volume":"351","author":"Coyle","year":"2004","journal-title":"N Engl J Med"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866310000755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866310000755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:25:42Z","timestamp":1759335942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866310000755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0248866310000755"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2009.04.010","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infections opportunistes non tuberculeuses au cours des traitements par les anti-TNF\u03b1","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2009.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Soci\u00e9t\u00e9 nationale fran\u00e7aise de m\u00e9decine interne (SNFMI). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}